These_DT studies_NNS may_MD have_VB important_JJ implications_NNS for_IN the_DT design_NN of_IN effective_JJ therapy_NN of_IN HIV-1_NN infection_NN ._.
These_DT studies_NNS demonstrate_VBP a_DT novel_JJ and_CC striking_JJ insensitivity_NN of_IN arterial_JJ endothelium_NN to_TO the_DT effects_NNS of_IN TNF_NN and_CC LPS_NN and_CC indicate_VBP a_DT dissociation_NN between_IN the_DT ability_NN of_IN HUAECs_NNS to_TO upregulate_VB nuclear_JJ factor-kappaB_NN and_CC VCAM-1_NN ._.
Stability_NN of_IN the_DT c-fos_NN and_CC c-jun_NN mRNA_NN was_VBD not_RB affected_VBN by_IN LTB4_NN ,_, as_IN assessed_VBN after_IN actinomycin_NN D_NN treatment_NN ._.
Rather_RB ,_, TNF_NN and_CC PMA_NN can_MD exert_VB effect_NN only_RB if_IN cells_NNS are_VBP in_IN an_DT appropriate_JJ redox_NN status_NN ,_, because_IN prior_JJ modification_NN toward_IN reduction_NN with_IN BHA_NN treatment_NN prevents_VBZ this_DT activation_NN ._.
We_PRP have_VBP demonstrated_VBN earlier_RBR that_IN the_DT crosslinkage_NN of_IN the_DT complex_NN with_IN the_DT CD2_NN antigen_NN results_VBZ in_IN the_DT proliferation_NN of_IN normal_JJ human_JJ T_NN cells_NNS ._.
In_IN contrast_NN to_TO wild-type_JJ B_NN cells_NNS ,_, neither_DT of_IN the_DT class_NN II_CD mutant_JJ cell_NN lines_NNS could_MD use_VB the_DT X_NN box_NN region_NN to_TO direct_VB the_DT expression_NN of_IN a_DT transiently_RB transfected_VBN reporter_NN gene_NN ,_, indicating_VBG that_IN the_DT X_NN box-dependent_JJ transcriptional_JJ pathway_NN is_VBZ defective_JJ in_IN these_DT cells_NNS ._.
Leukotriene_NN B4_NN stimulates_VBZ c-fos_NN and_CC c-jun_NN gene_NN transcription_NN and_CC AP-1_NN binding_NN activity_NN in_IN human_JJ monocytes_NNS ._.
Except_IN for_IN the_DT conserved_VBN zinc-finger_NN domains_NNS ,_, the_DT amino_NN acid_NN sequences_NNS of_IN the_DT three_CD proteins_NNS are_VBP distinct_JJ ._.
Expression_NN of_IN DR3_NN appears_VBZ to_TO be_VB restricted_JJ to_TO tissues_NNS enriched_VBN in_IN lymphocytes_NNS ._.
To_TO delineate_VB the_DT effects_NNS of_IN these_DT motifs_NNS on_IN the_DT replicative_JJ capacity_NN of_IN HIV_NN and_CC to_TO explore_VB the_DT possibility_NN of_IN extending_VBG the_DT virus_NN host_NN range_NN ,_, known_VBN heterologous_JJ were_VBD inserted_VBN into_IN the_DT HIV-1_NN LTR_NN in_IN place_NN of_IN the_DT NF-kappa_NN B_NN and_CC Sp1_NN binding_NN sites_NNS ._.
One_CD of_IN NF-kappa_NN B_NN unique_JJ properties_NNS is_VBZ posttranslational_JJ activation_NN via_IN release_NN of_IN an_DT inhibitory_JJ subunit_NN ,_, called_VBN inhibitor_NN of_IN NF-kappa_NN B_NN I_NN kappa_NN B_NN ,_, from_IN a_DT sequestered_JJ cytoplasmic_JJ form_NN ._.
In_IN this_DT study_NN we_PRP identified_VBD a_DT sequence_NN element_NN present_JJ in_IN the_DT most_RBS proximal_JJ region_NN located_JJ between_IN bases_NNS -214_CD and_CC -201_CD ,_, TTCTTCTAATTAA_NN ,_, which_WDT is_VBZ important_JJ in_IN the_DT high_JJ constitutive_JJ expression_NN of_IN CD20_NN in_IN mature_JJ B_NN cells_NNS and_CC the_DT induction_NN of_IN CD20_NN in_IN pre-B_JJ cells_NNS ._.
c-Jun_NN protein_NN isolated_VBN from_IN phorbol_NN ester-induced_JJ cells_NNS did_VBD not_RB target_VB c-Fos_NN for_IN degradation_NN ,_, which_WDT suggests_VBZ that_IN c-Fos_NN is_VBZ transiently_RB stabilized_VBN after_IN stimulation_NN of_IN cell_NN growth_NN ._.
We_PRP demonstrated_VBD ,_, by_IN applying_VBG the_DT electrophoretic_JJ mobility_NN shift_NN assay_NN ,_, slightly_RB impaired_JJ AP-1_NN DNA_NN binding_NN activity_NN in_IN NCL_NN lymphocytes_NNS and_CC strong_JJ in_IN DS_NN ones_NNS ._.
By_IN contrast_NN ,_, glucocorticoids_NNS failed_VBD to_TO inhibit_VB IFNalpha_NN production_NN from_IN AIDS-GR_NN monocytes_NNS approximately_RB 20_CD inhibition_NN ._.
To_TO determine_VB whether_IN specific_JJ members_NNS of_IN the_DT NF-kappa_NN B_NN family_NN contribute_VBP to_TO this_DT effect_NN ,_, we_PRP have_VBP examined_VBN the_DT abilities_NNS of_IN different_JJ NF-kappa_NN B_NN subunits_NNS to_TO act_VB with_IN Tat-I_NN to_TO stimulate_VB transcription_NN of_IN HIV_NN in_IN Jurkat_NN T-leukemia_NN cells_NNS ._.
Rapid_JJ nongenomic_JJ in_FW vitro_FW effects_NNS of_IN aldosterone_NN on_IN intracellular_JJ electrolytes_NNS ,_, cell_NN volume_NN ,_, and_CC antiport_NN have_VBP been_VBN found_VBN in_IN human_JJ mononuclear_JJ leukocytes_NNS HML_NN ._.
The_DT cytokine_NN TNF_NN mediates_VBZ many_JJ of_IN the_DT pathologic_JJ signs_NNS of_IN cachexia_NN ,_, inflammation_NN ,_, and_CC sepsis_NN ._.
This_DT sequence_NN element_NN was_VBD referred_VBN to_TO as_IN the_DT BAT_NN box_NN and_CC deletion_NN significantly_RB reduced_VBD the_DT activity_NN of_IN a_DT CD20_NN promoter-CAT_JJ construct_NN in_IN B_NN cells_NNS ._.
Cell_NN cycle-dependent_JJ initiation_NN and_CC lineage-dependent_JJ abrogation_NN of_IN GATA-1_NN expression_NN in_IN pure_JJ differentiating_VBG hematopoietic_JJ progenitors_NNS ._.
Here_RB we_PRP demonstrate_VBP that_IN the_DT human_JJ GM-CSF_NN promoter_NN and_CC enhancer_NN also_RB encompass_VBP binding_VBG sites_NNS for_IN core-binding_JJ factor_NN CBF_NN ._.
The_DT results_NNS suggest_VBP that_IN M-CSF_NN induction_NN of_IN M-CSF_NN involves_VBZ G_NN proteins_NNS ,_, PKC_NN and_CC NF_NN kappa_NN B_NN ._.
results_NNS suggest_VBP that_IN while_IN transfection_NN analyses_NNS offer_VBP an_DT adequate_JJ approximation_NN of_IN the_DT effects_NNS of_IN the_DT LS_NN mutations_NNS ,_, the_DT analysis_NN of_IN viral_JJ replication_NN using_VBG a_DT mutant_JJ viral_JJ stock_NN presents_VBZ a_DT more_RBR accurate_JJ picture_NN ,_, which_WDT is_VBZ sometimes_RB at_IN variance_NN with_IN the_DT transfection_NN results_NNS ._.
We_PRP have_VBP used_VBN a_DT 32P-labeled_JJ oligonucleotide_NN derived_VBN from_IN human_JJ immunodeficiency_NN virus_NN HIV-1_NN long_JJ terminal_JJ repeat_NN ,_, which_WDT contains_VBZ a_DT tandem_JJ repeat_NN of_IN the_DT NF_NN kappa_NN B_NN binding_NN sequence_NN ,_, as_IN a_DT probe_NN in_IN a_DT gel_NN retardation_NN assay_NN to_TO study_VB this_DT transcription_NN factor_NN ._.
We_PRP have_VBP now_RB investigated_VBN the_DT effect_NN of_IN oxLDLs_NNS on_IN blast_NN differentiation_NN ,_, on_IN IL-2_NN synthesis_NN and_CC on_IN the_DT activation_NN of_IN the_DT nuclear_JJ factor_NN kappaB_NN NF-kappaB_NN system_NN in_IN activated_VBN lymphocytes_NNS ._.
